pocketful logo light
pocketful logo light
Syngene International Ltd logo

Syngene International Ltd

NSE: SYNGENE BSE: 539268

₹440.75

(0.10%)

Wed, 24 Jun 2026, 08:28 am

mtf coin illustrationMTF 5x

Syngene International Share Price Live Chart

1 Day

(0.10%)

No Result Found

Summary

  • Market Cap (in Cr)

    17765.6

  • Net Profit (in Cr)

    496.2

  • P/B

    6.18

  • Sector P/E

    58.57

  • P/E

    58.89

  • EV/EBITDA

    25.33

  • Debt/Equity (Industry)

    0.42

  • Interest Cover (Industry)

    5.50

  • ROCE (Industry)

    12.55

  • RONW (Industry)

    12.45

  • ROE

    11.05

  • ROCE

    13.37

  • Debt/Equity

    0.13

  • EPS (TTM)

    9.32

  • Dividend Yield

    0.28

  • Book Value

    120.10

  • Interest Cover

    13.43

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters52.6852.6852.6852.6852.74
FII13.9014.9616.3116.5019.47
DII26.4425.8424.6224.0521.50
Public6.986.526.386.776.29
Government00000

Read More

Technical Analysis

RSI

45.40

MACD

-2.61

50 DMA

449.14

200 DMA

539.10

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic569.17512.97477.48456.77421.28400.57344.37
Fibonacci512.97491.50478.24456.77435.30422.04400.57
Camarilla457.45452.30447.15456.77436.85431.70426.55

Pivots Level: Classic

R3

+112.40

569.17

R2

+56.20

512.97

R1

+20.72

477.48

456.77
456.77
Pivot Point
LTP: 439.50

S1

-35.48

421.28

S2

-56.20

400.57

S3

-112.40

344.37

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    443.66

  • 20-EMA

    446.49

  • 30-EMA

    447.13

  • 50-EMA

    448.47

  • 100-EMA

    468.46

  • 200-EMA

    521.28

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
29 Apr 2026agm
29 Apr 2026dividend₹1.25 Dividend /Share26 Jun 2026
29 Apr 2026board-meetingsAccounts, Final Dividend
22 Jan 2026board-meetingsQuarterly Results
05 Nov 2025board-meetingsQuarterly Results, Half Yearly Results
27 May 2025dividendFinal Dividend - Rs. - 1.2527 Jun 2025
23 Apr 2025agm
23 Apr 2025dividend₹1.25 Dividend /Share27 Jun 2025
28 May 2024dividendFinal Dividend - Rs. - 1.2528 Jun 2024
24 Apr 2024dividend₹1.25 Dividend /Share28 Jun 2024

Read More

Peer Comparison

Syngene International Ltd logo

Syngene International Ltd

Aster DM Healthcare Ltd logo

Aster DM Healthcare Ltd

Max Healthcare Institute Ltd logo

Max Healthcare Institute Ltd

Narayana Hrudayalaya Ltd logo

Narayana Hrudayalaya Ltd

Apollo Hospitals Enterprise Ltd logo

Apollo Hospitals Enterprise Ltd

Fortis Healthcare Ltd logo

Fortis Healthcare Ltd

Read More

Syngene International Ltd About

Syngene International is engaged in providing contract research and manufacturing services from lead generation to clinical supplies to pharmaceutical and biotechnology companies worldwide. Syngene’s services include integrated drug discovery and development capabilities in medicinal chemistry, biology, in vivo pharmacology, toxicology, custom synthesis, process R&D, cGMP manufacturing, formulation and analytical development along with Clinical development services.

Industry

Miscellaneous

Founded

1993

Headquarters

CEO

Kiran Mazumdar Shaw

Employees

Contact

Website icon

Website

http://www.syngeneintl.com

Email icon

Email

investor@syngeneintl.com; Mayank.Verma@syngeneintl

Phone icon

Phone

91-80-68915000/67758781

Location icon

Location

Biocon SEZ Biocon Park, Plot No 2 & 3 Bommasandra Inds, Bengaluru, Karnataka, 560099

Read More

Syngene International Ltd Company History

YearHistory
2020
  • Syngene ties up with HiMedia Laboratories to manufacture ELISA test kits for COVID-19.
  • Syngene joins global industry consortium to accelerate collaborative research in COVID-19 testing.
  • Syngene and PharmAust collaborate to manufacture GMP-grade Monepantel for Human Clinical Trials.
  • Bioprocessing Excellence Award 2020.
2021
  • Syngene receives India Pharma Awards 2021.
  • Syngene Ranked As One Of The Top 100 Indian Wealth Creators For 2021.
  • Syngene International extends long term research collaboration with Bristol Myers Squibb until 2030.
  • Syngene through Biocon Foundation partners with NIMHANS for BHUMI.
2022
  • Syngene International takes top honors at CMO Leadership Awards 2022 for contract manufacturing.
  • Syngene signs 10-year biologics manufacturing agreement with leading animal health company.
  • Syngene and the Research and Innovation Circle of Hyderabad (RICH) launch scholarship program for women studying STEM subjects.
2023
  • Winner of India's Best Managed Companies 2023 programme
  • Supply Chain Champion Award, 2023
  • Best Overall Sustainable Performance (Pharmaceutical) 2023
  • Biopharma Excellence Award (India Edition) 2023
  • Panbela announces issuance of new patent in Australia.
2024
  • Syngene received Pharmaceutical Technology Excellence Awards 2024.
  • Syngene received Asia Pacific Biologics CMO Excellence Awards 2024.
  • Syngene awarded CDMO Leadership Awards 2024.
  • Syngene secures silver rating in EcoVadis sustainability index, ranking in top 15% of assessed companies.
  • Syngene launches platform for rapid, enhanced protein production.
  • Syngene International named as one of India's Best Managed Companies by Deloitte India.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
MICROCURVES TRADING PRIVATE LIMITEDbulkBuy2766287481.930 Apr 2026
NK SECURITIES RESEARCH PRIVATE LIMITEDbulkBuy2160599486.430 Apr 2026
MICROCURVES TRADING PRIVATE LIMITEDbulkSell2766287482.0230 Apr 2026
NK SECURITIES RESEARCH PRIVATE LIMITEDbulkSell2160599486.6230 Apr 2026
BIOCON LIMITEDbulkSell8000000857.6810 Dec 2024
GOVERNMENT OF SINGAPOREblockBuy1579920056001 Feb 2023
BIOCON LIMITEDblockSell1920000056001 Feb 2023
MONETARY AUTHORITY OF SINGAPOREblockBuy340080056001 Feb 2023
BIOCON LIMITEDblockSell375000056001 Feb 2023
MOTILAL OSWAL MUTUAL FUNDblockBuy170000056001 Feb 2023

Read More

Syngene International Ltd News

Syngene shareholders approve Mazumdar-Shaw's role change

Syngene International shareholders approved changing Ms. Kiran Mazumdar-Shaw's role from Non-Executive Chairperson to Executive Chairperson. The resolution passed with 91.4% of valid votes in favour.

19 Jun 2026

companies

Syngene to host analyst meet on June 19

Syngene International will hold a one-on-one meeting with LetterOne on June 19, 2026, in Bengaluru. The company confirmed no unpublished price sensitive information will be disclosed.

16 Jun 2026

companies

Syngene schedules analyst meetings

Syngene International Limited will meet analysts and investors on June 10-11, 2026. No unpublished price sensitive information will be disclosed.

05 Jun 2026

companies

Syngene dividend claim reminder

Syngene International reminds shareholders to claim unclaimed dividends for FY 2018-19 onwards by August 21, 2026, to avoid transfer to IEPF.

21 May 2026

companies

Syngene Seeks Shareholder nod

Syngene International seeks approval via postal ballot to appoint Kiran Mazumdar-Shaw as Executive Chairperson with annual remuneration of ₹4 crore.

20 May 2026

companies

Read More

Open Your Free Demat Account

Enter your phone number